These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 7568015

  • 21. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG, Sonsalla PK.
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [Abstract] [Full Text] [Related]

  • 22. Sorting of vesicular monoamine transporter 2 to the regulated secretory pathway confers the somatodendritic exocytosis of monoamines.
    Li H, Waites CL, Staal RG, Dobryy Y, Park J, Sulzer DL, Edwards RH.
    Neuron; 2005 Nov 23; 48(4):619-33. PubMed ID: 16301178
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.
    Weihe E, Schäfer MK, Erickson JD, Eiden LE.
    J Mol Neurosci; 1994 Nov 23; 5(3):149-64. PubMed ID: 7654518
    [Abstract] [Full Text] [Related]

  • 25. Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells.
    Liu Y, Edwards RH.
    J Cell Biol; 1997 Nov 17; 139(4):907-16. PubMed ID: 9362509
    [Abstract] [Full Text] [Related]

  • 26. The vesicular monoamine transporter VMAT2 and vesicular acetylcholine transporter VAChT are sorted to separate vesicle populations in PC12 cells.
    Tao-Cheng JH, Eiden LE.
    Adv Pharmacol; 1998 Nov 17; 42():250-3. PubMed ID: 9327891
    [No Abstract] [Full Text] [Related]

  • 27. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC, Vander Borght T, Sherman PS, Frey KA, Kilbourn MR.
    J Med Chem; 1996 Jan 05; 39(1):191-6. PubMed ID: 8568807
    [Abstract] [Full Text] [Related]

  • 28. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
    Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5166-71. PubMed ID: 8643547
    [Abstract] [Full Text] [Related]

  • 29. Autoradiographic distribution of the eye monoaminergic synaptic vesicles.
    Denis P, Nordmann JP, Scherman D, Saraux H, Rostène W.
    Ophthalmic Res; 1994 May 14; 26(4):232-9. PubMed ID: 7808734
    [Abstract] [Full Text] [Related]

  • 30. Snap-25 is polarized to axons and abundant along the axolemma: an immunogold study of intact neurons.
    Tao-Cheng JH, Du J, McBain CJ.
    J Neurocytol; 2000 Jan 14; 29(1):67-77. PubMed ID: 11068335
    [Abstract] [Full Text] [Related]

  • 31. Serotonin transporters (SERTs) within the rat nucleus of the solitary tract: subcellular distribution and relation to 5HT2A receptors.
    Huang J, Pickel VM.
    J Neurocytol; 2002 Jan 14; 31(8-9):667-79. PubMed ID: 14501206
    [Abstract] [Full Text] [Related]

  • 32. Immunogold labeling of synaptic vesicle proteins in developing hippocampal neurons.
    Tao-Cheng JH.
    Mol Brain; 2020 Jan 20; 13(1):9. PubMed ID: 31959215
    [Abstract] [Full Text] [Related]

  • 33. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
    Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI.
    J Comp Neurol; 1997 Nov 17; 388(2):211-27. PubMed ID: 9368838
    [Abstract] [Full Text] [Related]

  • 34. Murine vesicular monoamine transporter 2: molecular cloning and genomic structure.
    Takahashi N, Uhl G.
    Brain Res Mol Brain Res; 1997 Oct 03; 49(1-2):7-14. PubMed ID: 9387858
    [Abstract] [Full Text] [Related]

  • 35. Identified neurons in C. elegans coexpress vesicular transporters for acetylcholine and monoamines.
    Duerr JS, Gaskin J, Rand JB.
    Am J Physiol Cell Physiol; 2001 Jun 03; 280(6):C1616-22. PubMed ID: 11350757
    [Abstract] [Full Text] [Related]

  • 36. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release.
    Persico AM, Mengual E, Moessner R, Hall FS, Revay RS, Sora I, Arellano J, DeFelipe J, Gimenez-Amaya JM, Conciatori M, Marino R, Baldi A, Cabib S, Pascucci T, Uhl GR, Murphy DL, Lesch KP, Keller F.
    J Neurosci; 2001 Sep 01; 21(17):6862-73. PubMed ID: 11517274
    [Abstract] [Full Text] [Related]

  • 37. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system.
    Hansson SR, Hoffman BJ, Mezey E.
    Brain Res Dev Brain Res; 1998 Sep 10; 110(1):135-58. PubMed ID: 9733951
    [Abstract] [Full Text] [Related]

  • 38. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.
    Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH.
    Neuron; 1997 Dec 10; 19(6):1271-83. PubMed ID: 9427250
    [Abstract] [Full Text] [Related]

  • 39. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
    Erickson JD, Eiden LE, Schafer MK, Weihe E.
    J Mol Neurosci; 1995 Dec 10; 6(4):277-87. PubMed ID: 8860238
    [Abstract] [Full Text] [Related]

  • 40. The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons.
    Chaudhry FA, Reimer RJ, Bellocchio EE, Danbolt NC, Osen KK, Edwards RH, Storm-Mathisen J.
    J Neurosci; 1998 Dec 01; 18(23):9733-50. PubMed ID: 9822734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.